Dtsch Med Wochenschr 2008; 133(12): 591-594
DOI: 10.1055/s-2008-1067291
Kommentar | Commentary
Kardiologie, Pathophysiologie
© Georg Thieme Verlag KG Stuttgart · New York

Kardiologische Optionen der Akutprotektion des reperfundierten Myokards

Cardiological options for acute protection of the reperfused myocardiumF. Breuckmann1 , G. Heusch2 , R. Erbel1 , S. Philipp1
  • 1Klinik für Kardiologie, Westdeutsches Herzzentrum Essen
  • 2Institut für Pathophysiologie, Universität Duisburg-Essen
Further Information

Publication History

eingereicht: 3.12.2008

akzeptiert: 14.2.2008

Publication Date:
12 March 2008 (online)

Literatur

  • 1 Armstrong P W, Adams P X, Al-Khalidi H R, Hamm C, Holmes D, O’Neill W, Todaro T G, Vahanian A, van de Werf F, Granger C B. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.  Amer Heart J. 2005;  149 (3) 402-7
  • 2 Darling C E, Solari P B, Smith C S, Furman M I, Przyklenk K. ‘Postconditioning’ the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection.  Basic Res Cardiol. 2007;  102 (3) 274-278
  • 3 Heusch G, Schulz R. Ischämische Prä- und Postkonditionierung.  Dtsch Med Wochenschr. 2006;  39 2169-75
  • 4 Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H, Kitamura S. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.  Lancet. 2007;  370 (9597) 1483-93
  • 5 Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.  Circulation. 1986;  74 (5) 1124-36
  • 6 Philipp S, Yang X -M, Cui L, Davis A, Downey J M, Cohen M V. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade.  Cardiovasc Res. 2006;  70 (2) 308-14
  • 7 Roe M. ACC 07: Die DELTA MI-Studie.  Herz. 2007;  32 250
  • 8 Ross A M, Gibbons R J, Stone G W, Kloner R A, Alexander R W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).  J Am Coll Cardiol. 2005;  45 (11) 1775-80
  • 9 Staat P, Rioufol G, Piot C, Cottin Y, Cung T T, L’Huillier I, Aupetit J F, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M. Postconditioning the human heart.  Circulation. 2005;  112 (14) 2143-8
  • 10 Zhao Z Q, Corvera J S, Halkos M E, Kerendi F, Wang N -P, Guyton R A, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.  Am J Physiol. 2003;  285 H579-H588

Dr. med. Frank Breuckmann

Klinik für Kardiologie, Westdeutsches Herzzentrum Essen, Universität Duisburg-Essen

Hufelandstr. 55

45122 Essen

Phone: 0201/723-4888

Fax: 0201/723-5401

Email: frank.breuckmann@uk-essen.de

    >